Andy Molnar, CEO of the Digital Therapeutics Alliance, has been selected to serve on the FDA’s Digital Health Advisory Committee (DHAC). The committee advises the FDA commissioner on digital health technologies like AI, machine learning, and virtual reality, ensuring safe and effective regulation. Molnar will be responsible for areas like real-world data, digital diagnostics, and decentralized clinical trials. Arrive AI announced new appointments to its board, including John Gallina and Jim Brainard, to help develop their smart mailbox platform for healthcare organizations. CareAbout Health appointed Masoud Nourmohammadi as its new chief technology officer to drive innovation in value-based care. The HIMSS Healthcare Cybersecurity Forum is set to take place in Washington, D.C.
Source link
Digital Therapeutics Alliance CEO joins FDA Digital Health Advisory Committee and more digital health news
